FindMyKOL
Clinical trialNCT01336855RecruitingObservational

Collection of Blood for Multiple Collaborative Studies

NCT01336855 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV. The registry lists an enrollment of 2,000 participants at 1 site in 1 country. The registry lists a start date of 31 Jan 1988 and a primary completion date of 31 Jan 2030. One of its registered investigators has a FindMyKOL profile.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01336855
FieldValue
Registry IDNCT01336855
StatusRecruiting
Study typeObservational study
Lead sponsorUniversity of California, San Francisco
Enrollment2,000
Registered sites1
Countries1
ConditionsHIV
Start31 Jan 1988
Primary completion31 Jan 2030
Study completion31 Jan 2030
Last update posted13 Apr 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site, 1 recruiting
  • San Francisco General Hospital

    San Francisco

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 site, 1 recruitingCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01336855

Each answer restates registry values shown on this page.

What is NCT01336855?

NCT01336855 is an observational study sponsored by University of California, San Francisco. It studies HIV.

Is NCT01336855 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT01336855?

The registry names Steven Deeks, M.D. (principal investigator, University of Californa, San Francisco) as the overall official.

Where does NCT01336855 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT01336855 expected to complete?

The registry lists a primary completion date of 31 Jan 2030 and a study completion date of 31 Jan 2030. The sponsor last updated the record on 13 Apr 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.